Skip to main content

DVS Sciences Raises $14.6M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DVS Sciences today announced it has raised $14.6 million in a Series A financing round, which will be used to build up the company's manufacturing capabilities for its multiplexed single cell analysis technology.

The platform called CyTOF-Maxpar comprises a high-throughput mass cytometer for individual cell analysis and the company's Maxpar reagents. The technology can simultaneous identify up to 100 biomarkers with "very high" resolution and a wide dynamic range, DVS said, and the platform eliminates spectral overlap issues and enables quantitative, highly multiplexed biomarker analysis.

Spun out of the University of Toronto last year, DVS has offices in Toronto and Sunnyvale, Calif.

Investors in the Series A round include 5AM Ventures, Pfizer Venture Investments, Mohr Davidow, the Roche Venture Fund, and the Ontario Institute for Cancer Research.

"This significant Series A financing puts us in a position to broadly commercialize our innovative instrumentation and reagents to help scientists accelerate biomedical research, enable personalized therapeutic diagnosis and prognosis, and transform drug discovery," Scott Tanner, CEO and Co-founder of DVS, said in a statement.

Andrew Schwab, venture partner at 5AM Ventures, added, "We believe that the CyTOF-Maxpar platform will transform the performance of cellular analysis. By enabling massively multiplexed experiments, researchers will be primed to better understand the cellular dynamics of disease states, stem cells, and other biologically relevant systems."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.